Welcome to DNAIQ
Advanced genomic analysis for clinical and research applications.
DNA sequencing generates vast datasets containing critical information for medical diagnosis, therapeutic development, and biological research. The challenge lies in extracting meaningful insights from complex genomic data.
DNAIQ provides comprehensive genomic analysis services combining laboratory operations, bioinformatics, and clinical research expertise. Our integrated approach transforms raw genetic data into clinically actionable information.
We deliver precision genomic solutions for healthcare organizations, research institutions, and biotechnology companies requiring reliable, scalable genetic testing and analysis capabilities.
Precision. Accuracy. Innovation.
About DNAIQ
Precision genomic testing and analysis for clinical, research, and commercial applications.
Company Overview
Founded in 2013, DNAIQ is a Melbourne-based genomics laboratory providing specialized testing services for clinical diagnostics, research applications, and commercial genomics programs.
We operate state-of-the-art sequencing platforms and maintain quality standards required for clinical-grade genomic testing. Our team includes molecular biologists, bioinformaticians, and clinical geneticists.
Our Mission
To deliver accurate, reliable genomic testing services that enable clinical decision-making, advance scientific research, and support commercial genomics applications.
Our Vision
To make genomic information accessible and actionable for improved patient outcomes and scientific advancement.
The Science Behind Genomics
DNA: The Blueprint of Life
Deoxyribonucleic acid (DNA) is the hereditary material that contains the genetic instructions for the development, functioning, growth and reproduction of all known living organisms. Composed of four nucleotide bases - Adenine (A), Thymine (T), Guanine (G), and Cytosine (C) - DNA forms the foundation of genetic variation and inheritance.
The human genome contains approximately 3.2 billion base pairs, encoding roughly 20,000-25,000 protein-coding genes. However, the non-coding regions, once considered "junk DNA," are now understood to play crucial regulatory roles in gene expression and cellular function.
Genetic Variation and SNPs
Single Nucleotide Polymorphisms (SNPs) are the most common type of genetic variation among people. Each SNP represents a difference in a single DNA building block, called a nucleotide. SNPs occur normally throughout a person's DNA, roughly once in every 300 nucleotides.
These variations can influence disease risk, drug response, and other traits. Understanding SNP patterns across populations enables personalized medicine approaches and helps identify genetic factors contributing to complex diseases.
Epigenetics: Beyond the Sequence
Epigenetics refers to heritable changes in gene expression that don't involve changes to the underlying DNA sequence. These modifications, including DNA methylation and histone modifications, can be influenced by environmental factors and play crucial roles in development, aging, and disease.
Epigenetic marks can be dynamic and reversible, offering potential therapeutic targets for various conditions including cancer, neurological disorders, and metabolic diseases.
Advanced Genomic Technologies
Next-Generation Sequencing (NGS)
NGS technologies have revolutionized genomics by enabling massive parallel sequencing of DNA fragments. These platforms can sequence entire genomes, exomes, or targeted gene panels with unprecedented speed and accuracy, generating terabytes of data in a single run.
Modern sequencing platforms include Illumina's short-read technology, Pacific Biosciences' long-read sequencing, and Oxford Nanopore's real-time sequencing, each offering unique advantages for different applications.
Microarray and Genotyping Arrays
Genotyping arrays provide a cost-effective method for analyzing hundreds of thousands to millions of genetic variants simultaneously. These platforms are ideal for genome-wide association studies (GWAS), pharmacogenomics, and population genetics research.
Modern arrays can detect SNPs, copy number variations (CNVs), and structural variants with high accuracy and reproducibility, making them essential tools for large-scale genetic studies.
Bioinformatics and Data Analysis
The explosion of genomic data requires sophisticated computational approaches for storage, analysis, and interpretation. Machine learning algorithms, statistical models, and cloud computing platforms enable researchers to extract meaningful insights from complex datasets.
Our bioinformatics pipelines integrate quality control, variant calling, annotation, and interpretation workflows to transform raw sequencing data into clinically actionable information.
Artificial Intelligence in Genomics
AI and machine learning are transforming genomic analysis through deep learning models that can identify complex patterns in genetic data. These approaches enable more accurate variant interpretation, drug discovery, and personalized treatment recommendations.
Neural networks and ensemble methods are particularly effective for predicting the functional impact of genetic variants and identifying novel therapeutic targets.
Our Services
Contract Laboratory Services
Comprehensive genomic testing services including whole genome sequencing, exome sequencing, targeted gene panels, and pharmacogenomic testing with industry-leading quality standards.
Clinical Genomics
Clinical-grade genetic testing for diagnostic applications, including rare disease diagnosis, cancer genomics, and reproductive health screening with comprehensive reporting.
Pharmacogenomics
Personalized medicine solutions analyzing genetic variants that affect drug metabolism, efficacy, and adverse reactions to optimize therapeutic outcomes.
Bioinformatics Solutions
Custom bioinformatics pipelines, data analysis workflows, and interpretation services to transform genomic data into actionable insights.
Research & Development
Current Research Focus
Precision Medicine
Developing genomic biomarkers for personalized treatment strategies in oncology, cardiology, and psychiatry.
Rare Disease Genomics
Advanced sequencing and analysis techniques for diagnosing ultra-rare genetic conditions and novel gene discovery.
Population Genomics
Large-scale genomic studies to understand genetic diversity, disease susceptibility, and therapeutic response across populations.
Multi-Omics Integration
Combining genomics, transcriptomics, proteomics, and metabolomics data for comprehensive biological understanding.
Regulatory Affairs
Our regulatory team provides expertise in navigating the complex landscape of genomic testing regulations, including TGA requirements, NATA accreditation standards, ISO quality management systems, and AHPRA policies and guidelines.
We support clients through the entire regulatory process, from test development and validation to market approval and post-market surveillance, ensuring compliance with Australian healthcare regulatory frameworks.
Partnerships & Collaborations
DNAIQ collaborates with leading academic institutions, biotechnology companies, and healthcare organizations to advance genomic research and translate discoveries into clinical applications.
Contact Us
info@dnaiq.com
Phone
+61 499 299 282
Laboratory Address
Rear of 283 Burke Road
Glen Iris, Victoria 3146
Australia
Discuss Your Genomic Testing Requirements
Contact us to discuss your genomic testing and analysis requirements. Our technical team can provide detailed information about our capabilities and service offerings.
Latest Genomics News
Stay informed with the latest developments in genomics and precision medicine from Nature Publishing Group.
News content sourced from Nature Publishing Group. DNAIQ is not affiliated with Nature Publishing Group.